A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

NCT00404508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Refractory Solid Tumors

Interventions

DRUG: Hydralazine and magnesium valproate

Sponsor

National Institute of Cancerología

Collaborators

[object Object]
[object Object]